WST
West Pharmaceutical Services · Health Care
12.0%
typical move (median |reaction| of last 8)
2026-10-22 pre · likely
next expected · estimated from pattern
12
scored events
Last eight reactions
2024-10-24 → 2026-07-23
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-07-23 | pre | -0.8% | 0.8% | -5.1% | -3.8% |
| 2026-04-23 | pre | +12.8% | 12.8% | -5.2% | -2.6% |
| 2026-02-12 | pre | -1.3% | 1.3% | -2.1% | -0.5% |
| 2025-10-23 | pre | +11.2% | 11.2% | -10.6% | -13.2% |
| 2025-07-24 | pre | +22.6% | 22.6% | -13.8% | -13.2% |
| 2025-04-24 | pre | -3.1% | 3.1% | -2.1% | -7.5% |
| 2025-02-13 | pre | -38.5% | 38.5% | +7.9% | +23.7% |
| 2024-10-24 | pre | +15.4% | 15.4% | -4.9% | -5.4% |
Source filings
2026-07-23 · 8-K press release
West Reports Second-Quarter 2026 Results Raising Full-Year Net Sales and EPS guidance Exton, PA, July 23, 2026 – West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-
2026-04-23 · 8-K press release
West Reports First-Quarter 2026 Results – Strong Start to the Year and Raising Full Year Revenue and EPS guidance Exton, PA, April 23, 2026 – West Pharmaceutical Services, Inc. (NYSE: WST), a leading
2026-02-12 · 8-K press release
West Reports Fourth-Quarter and Full-Year 2025 Results – Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – Exton, PA, F
2025-10-23 · 8-K press release
West Reports Third-Quarter 2025 Results - Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components - - Strengthened exe
2025-07-24 · 8-K press release
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance - Conference Call Scheduled fo r 8 a.m. EDT Today - Exton, PA, July 24, 2025 – West Pharmac
2025-04-24 · 8-K press release
West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 24, 2025
2025-02-13 · 8-K press release
West Announces Fourth-Quarter and Full-Year 2024 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, February 13, 2025 – West Pharmaceutical Services, Inc. (NYSE: WST) today announce
2024-10-24 · 8-K press release
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 24, 2024